• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Detection and quantification of infectious severe acute respiratory coronavirus-2 in diverse clinical and environmental samples

tetano

Editor, Senior Moderator
Sci Rep


. 2022 Mar 30;12(1):5418.
doi: 10.1038/s41598-022-09218-5.
Detection and quantification of infectious severe acute respiratory coronavirus-2 in diverse clinical and environmental samples


Yi-Chan Lin[SUP] 1 [/SUP], Rebecca J Malott[SUP] 2 [/SUP], Linda Ward[SUP] 2 3 [/SUP], Linet Kiplagat[SUP] 2 [/SUP], Kanti Pabbaraju[SUP] 4 [/SUP], Kara Gill[SUP] 4 [/SUP], Byron M Berenger[SUP] 2 4 [/SUP], Jia Hu[SUP] 2 [/SUP], Kevin Fonseca[SUP] 2 3 4 [/SUP], Ryan S Noyce[SUP] 1 [/SUP], Thomas Louie[SUP] 2 3 [/SUP], David H Evans[SUP] 5 [/SUP], John M Conly[SUP] 2 3 [/SUP]



Affiliations

Abstract

To explore the potential modes of Severe Acute Respiratory Coronavirus-2 (SARS-CoV-2) transmission, we collected 535 diverse clinical and environmental samples from 75 infected hospitalized and community patients. Infectious SARS-CoV-2 with quantitative burdens varying from 5 plaque-forming units/mL (PFU/mL) up to 1.0 × 10[SUP]6[/SUP] PFU/mL was detected in 151/459 (33%) of the specimens assayed and up to 1.3 × 10[SUP]6[/SUP] PFU/mL on fomites with confirmation by plaque morphology, PCR, immunohistochemistry, and/or sequencing. Infectious virus in clinical and associated environmental samples correlated with time since symptom onset with no detection after 7-8 days in immunocompetent hosts and with N-gene based C[SUB]t[/SUB] values ≤ 25 significantly predictive of yielding plaques in culture. SARS-CoV-2 isolated from patient respiratory tract samples caused illness in a hamster model with a minimum infectious dose of ≤ 14 PFU. Together, our findings offer compelling evidence that large respiratory droplet and contact (direct and indirect i.e., fomites) are important modes of SARS-CoV-2 transmission.
 
Back
Top Bottom